Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

The New Generation of Blockbusters: Pipeline Potential, 2002-2008

Published by: Datamonitor

Published: Jun. 5, 2002 - 29 Pages


Table of Contents


Introduction

Strategic considerations in the blockbuster market

Breakdown of potential blockbuster sales by company

Therapeutic focus of potential new blockbusters

Overview

Cardiovascular

CNS

Arthritis and pain

Diabetes

Cancer

Infectious diseases

Respiratory

Others

Conclusions

© Datamonitor 2002. All Rights Reserved.

Abstract

Analysis of current pipeline drugs with the potential to become blockbusters by 2008 and segmentation by company and therapy area - Introduction: This analysis identifies the 18 drugs currently in the pipeline that Datamonitor forecasts have the potential to become blockbusters by 2008. By segmenting the pipeline blockbusters by company and by therapy area, the brief identifies the winners and losers in the battle for the next generation of best sellers. Key Reasons To Purchase This Profile: * Understand why AstraZeneca and Eli Lilly are forecast to be the major winners in the race for new blockbusters * Evaluate the therapeutic breakdown of the next generation of blockbusters and understand why cardiovascular disease will continue to dominate the market.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009